Inventor
Kevin J. Hodgetts
Inventor
Killingworth, CT, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes10%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
Y02ATechnologies for adaptation to climate change6%
A01KAnimal husbandry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,961,254Pyrimidine compounds and methods using the same202110,787,433Pyridazine derivatives as EAAT2 activators202010,420,753Combination therapies for treatment of spinal muscular atrophy201910,336,768Pyrimidine compounds and methods using the same20199,895,358'Combination therapies for treatment of spinal muscular atrophy'20189,630,947'Therapeutic compounds and related methods of use'20179,133,204'5-membered heterocyclic amides and related compounds'20159,073,890'Therapeutic compounds and related methods of use'20158,580,812'Heteroaryl amide analogues as P2X7 antagonists'20137,935,702'Substituted biaryl quinolin-4-ylamine analogues'20117,488,740'Substituted quinolin-4-ylamine analogues'20097,432,275'Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators'20087,304,059'Substituted quinazolin-4-ylamine analogues'20077,202,250'Substituted arylpyrazines'20077,179,807'5-substituted-2-arylpyrazines'20077,169,790'5-substituted 2-aryl-4-pyrimidinones'20077,074,799'Substituted quinazolin-4-ylamine analogues'20067,074,929'Certain alkylene diamine-substituted heterocycles'20066,995,161'Substituted arylpyrazines'20066,943,173'5-substituted 2-aryl-4-pyrimidinones'20056,723,730'Capsaicin receptor ligands'20046,696,445'Certain alkylene diamine-substituted heterocycles'20046,509,366'Substituted imidazoles as selective modulators of Bradykinin B2 receptors'20036,506,762'Certain alkylene diamine-substituted heterocycles'20036,420,365'Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptors'20026,403,591'1-azatricyclic-4-benzylpiperazines'20026,294,530'1-azatricyclic-4-benzylpiperazines'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2011Patents assigned to NEUROGEN CORP (17)· patent assignee history
2001–2002Based in Branford, CT, US· patent location history
2002–2011Based in Killingworth, CT, US· patent location history
2003–2006Patents assigned to PFIZER (3)· patent assignee history
2013–2015Patents assigned to LUNDBECK & CO AS H (2)· patent assignee history
2013Based in Waterford, CT, US· patent location history
2015–2017Patents assigned to OTSUKA PHARMA CO LTD (2)· patent assignee history
2015–2021Based in Framingham, MA, US· patent location history
2015Based in Natick, MA, US· patent location history
2018–2021Patents assigned to BRIGHAM & WOMENS HOSPITAL INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEUROGEN CORP | 17 | 2001–2011 |
| BRIGHAM & WOMENS HOSPITAL INC | 5 | 2018–2021 |
| PFIZER | 3 | 2003–2006 |
| LUNDBECK & CO AS H | 2 | 2013–2015 |
| OTSUKA PHARMA CO LTD | 2 | 2015–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Killingworth, CT, US | 15 | 2002–2011 |
| Framingham, Massachusetts, US | 7 | 2015–2021 |
| Branford, CT, US | 2 | 2001–2002 |
| Natick, Massachusetts, US | 1 | 2015 |
| Waterford, CT, US | 1 | 2013 |